Orca Bio Funding: $300M Raised, Series D (2020)

Orca Bio funding overview

Orca Bio is based in Menlo Park, CA. Orca Bio has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in June 2020. The round record for Orca Bio runs through 2020; nothing later has been disclosed. Investors on record include Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals and 2 others. 8 distinct backers are named across the disclosed rounds.

Orca Bio at a glance

Total raised: $300M
Latest round: Series D
Latest round date: June 2020
Headquarters: Menlo Park, CA
Notable investors: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals, Kaiser Permanente Group Trust, IMRF

Frequently asked about Orca Bio funding

How much has Orca Bio raised?: Orca Bio has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Orca Bio?: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals are named among the investors backing Orca Bio.
What was the latest Orca Bio funding round?: The most recent disclosed round is a Series D, announced in June 2020.
Where is Orca Bio based?: Orca Bio is based in Menlo Park, CA.
When did Orca Bio last raise?: The last disclosed Orca Bio round closed in June 2020 at Series D.

Round data for Orca Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Menlo Park and backer lists below.

Orca Bio Funding: $300M Raised, Series D (2020)

Orca Bio funding overview

Orca Bio at a glance

Frequently asked about Orca Bio funding

Companies related to Orca Bio (36)

Browse related funding lists (6)